The AbbVie file tumbled to a two-year low after the pharmaceutical company announced an agreement to buy Allergan. Shortly afterwards, three AbbVie insiders began in stock.
AbbVie (ticker: ABBV) announced the bid for Allergan (AGN) tomorrow, June 25, the same day. The AbbVie shares put a multiyear intraday low at $ 65.06. They have not traded at this level since May 2017.